National & World News

 
Pharmstar Pharmaceuticals Inc  PHAR
 Performance   more  
Growth of $10,00006-15-12
Total Return%200920102011YTD
 Stock5733.3-100.0-22.0-76.9
 +/- Industry5726.9-103.9-31.8-90.9
 +/- S&P 5005709.9-112.8-22.0-83.7
 
 Key Stats   
Last Close (06-15-12)$.00
Market Cap $Mil---
Sales $Mil1
Morningstar Style Box ---
Industry Biotechnology
Sector Healthcare
Stock Type  Speculative Growth
Morningstar Stock Grades
Growth  NA
Profitability  NA
Financial Health NA
 Valuation   more  06-15-12 
StockIndustryS&P 500
Price/Earnings---42.0---
Forward P/E------13.6
Price/Book---5.82.2
Price/Cash Flow---27.47.7
Price/Sales---5.71.3
Dividend Yield %------2.1
S&P 500 data through 06-15-12
 Growth   more  09-30-04 
1 Year%
3 Year%
S&P 500
Sales314.6---8.4
Net Income------12.7
EPS------13.1
Equity/Share------11.7
Dividends------4.2
S&P 500 data - 3 Year%
 Profitability   more  06-30-05 
StockIndustryS&P 500
ROA %-105.66.79.4
ROE %-439.613.522.8
  Net Margin %-601.813.714.0
  Asset Turnover0.20.50.8
  Fin Leverage4.87.7
Sales/Employee
$Thousands
52.3------
Stock uses trailing 12 months. Industry and S&P 500 use fiscal year-end.
 Earnings Trends   more  06-30-05 
Historical years use fiscal year-end.
 Fund Ownership  more  
 % Shares Held % Fund Assets Star Rating
   Not Rated
Become a Morningstar Premium Member. Enjoy our analyst picks and buy-sell opinions on 3,800 stocks, funds and ETFs. Learn more.

© Copyright 2013 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc.
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.